High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy

Massimo Federico*, Monica Bellei, Pauline Brice, Maura Brugiatelli, Arnon Nagler, Christian Gisselbrecht, Luciano Moretti, Philippe Colombat, Stefano Luminari, Francesco Fabbiano, Nicola Di Renzo, Anthony Goldstone, Angelo Michele Carella

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences